Articles dans des revues avec comité de lecture (161)
109.
Najar, M., Rouas, R., Raicevic, G., Boufker, H. I., Lewalle, P., Meuleman, N., Bron, D., Toungouz Nevessignsky, M., Martiat, P., & Lagneaux, L. (2009). Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy, 11(5), 570-583. doi:10.1080/14653240903079377110.
Defoiche, J., Debacq, C., Asquith, B., Zhang, Y., Burny, A., Bron, D., Lagneaux, L., Macallan, D., & Willems, L. (2008). Reduction of B cell turnover in chronic lymphocytic leukaemia. British journal of haematology, 143(2), 240-247. doi:10.1111/j.1365-2141.2008.07348.x111.
Meuleman, N., Stamatopoulos, B., Dejeneffe, M., El Housni, H., Lagneaux, L., & Bron, D. (2008). Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia, 22(10), 1882-1890. doi:10.1038/leu.2008.190112.
Tondreau, T., Dejeneffe, M., Meuleman, N., Stamatopoulos, B., Delforge, A., Martiat, P., Bron, D., & Lagneaux, L. (2008). Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC genomics, 9, 166. doi:10.1186/1471-2164-9-166113.
Meuleman, N., Vanhaelen, G., Tondreau, T., Lewalle, P., Kwan, J., Bennani, J., Martiat, P., Lagneaux, L., & Bron, D. (2008). Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica, 93(1), e11-e13. doi:10.3324/haematol.11802114.
Meuleman, N., Tondreau, T., Vanhaelen, G., Lagneaux, L., & Bron, D. (2008). Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report. Haematologica, 93(5), e48.115.
Meuleman, N., Vanhaelen, G., Tondreau, T., Lewalle, P., Kwan, J., Bennani, J., Martiat, P., Lagneaux, L., & Bron, D. (2008). Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation (HSCT) with Mesenchymal Stromal Cell (MSC) infusion for the Treatment of Metachromatic Leukodystrophy (MLD): A case report. Haematologica, 93(1), 48.116.
Lagneaux, L., Gillet, N., Stamatopoulos, B., Delforge, A., Dejeneffe, M., Massy, M., Meuleman, N., Kentos, A., Martiat, P., Willems, L., & Bron, D. (2007). Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Experimental hematology, 35(10), 1527-1537. doi:10.1016/j.exphem.2007.06.014117.
Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Duvillier, H., Massy, M., Martiat, P., Bron, D., & Lagneaux, L. (2007). Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clinical chemistry, 53(10), 1757-1766. doi:10.1373/clinchem.2007.089326118.
Meuleman, N., Ahmad, I., Duvillier, H., Lemort, M., Bennani, J., Martiat, M., Lagneaux, L., & Bron, D. (2006). Intrathecal donor lymphocyte infusion for the treatment of suspected refractory lymphomatous meningitis: a case report. European journal of haematology, 77(6), 523-526. doi:10.1111/j.0902-4441.2006.t01-1-EJH2498.x119.
Cardoso, F., Durbecq, V., Laes, J.-F., Badran, B., Lagneaux, L., Bex, F., Desmedt, C., Willard-Gallo, K., Ross, J. S., Burny, A., Piccart-Gebhart, M., & Sotiriou, C. (2006). Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner. Molecular cancer therapeutics, 5(12), 3042-3051. doi:10.1158/1535-7163.MCT-06-0104120.
Meuleman, N., Tondreau, T., Delforge, A., Dejeneffe, M., Massy, M., Libertalis, M., Bron, D., & Lagneaux, L. (2006). Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. European journal of haematology, 76(4), 309-316. doi:10.1111/j.1600-0609.2005.00611.x